U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Pantoprazole Sodium for Injection
Status: Currently in Shortage
»Date first posted: 05/28/2019
»Therapeutic Categories: Gastroenterology

Expand all

Eugia Pharma Specialties LTD. (formerly Aurobindo) (Reverified 05/01/2023)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg, 10 vials (NDC 55150-202-10) Available Check wholesalers for inventory Available

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 05/16/2023)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg, 10 vials (NDC 0143-9284-10) Inventory is currently available. Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug

Hospira, Inc., a Pfizer company (Revised 05/15/2023)

Company Contact Information:
800-533-4535

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg, 10 vials (NDC 0008-0923-55) Limited Supply Available. Next Delivery: May 2023; Estimated Recovery: June 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
40 mg, 25 vials (NDC 0008-0923-60) Limited Supply Available. Next Delivery: May 2023; Estimated Recovery: June 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
40 mg, 10 vials (NDC 0008-4001-10; PremierProRx) Available Other
40 mg, 25 vials (NDC 0008-4001-25; PremierProRx) Next Delivery: May 2023; Estimated Recovery: December 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other

Sandoz (Revised 05/26/2023)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg, 10 vials (NDC 0781-3232-95) Limited Availability Demand increase for the drug
40 mg, 10 vials (NDC 72572-550-10) Available Marketed by Civica
40 mg, Package of 10 vials (NDC 0480-4111-03) Discontinuation of the manufacture of the product Marketed by Teva Demand increase in the drug
40 mg, package of 10 vials (NDC 65219-433-15) Limited supply Marketed by Fresenius Kabi Demand increase for the drug

Sun Pharmaceutical Industries Inc. (Revised 04/05/2022)

Company Contact Information:
800-818-4555

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg, 10 vials (NDC 62756-129-44) Available Other
Back to Top